Key result
N-arachidonoyl taurine (70 μM) restored channel gating and increased current amplitude in diverse Long QT syndrome-associated IKs channel mutants by shifting the voltage dependence of activation by 30-50 mV towards more negative voltages.
Why the study?
Does N-arachidonoyl taurine restore function in IKs channels with diverse Long QT mutations?
Population
IKs channels with diverse Long QT syndrome-associated loss-of-function mutations
Design
Preclinical
Authors
Loading...
May offer a mutation-agnostic prototype for Long QT; leaves open translation from animal models to patients.
Does N-arachidonoyl taurine restore function in IKs channels with diverse Long QT mutations?
N-arachidonoyl taurine serves as a promising prototype compound that restores function in diverse mutant IKs channels, highlighting a potential therapeutic strategy for Long QT syndrome.
Liin et al. (2016) studied Long QT syndrome (LQTS). N-arachidonoyl taurine (N-AT) vs. Control solution was evaluated on Shift in conductance versus voltage curve (G(V)) and channel opening kinetics. N-arachidonoyl taurine (70 μM) restored channel gating and increased current amplitude in diverse Long QT syndrome-associated IKs channel mutants by shifting the voltage dependence of activation by 30-50 mV towards more negative voltages.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: